Importante *No es un medicamento y no reemplaza tratamientos mdicos ni est aprobado como tratamiento contra enfermedades o condiciones especficas
Thats why youll go through a full medical evaluation, and why we monitor labs, side effects, and response during the program.
availability varies by state) Non-GLP-1 medications : Options like metformin, bupropion-naltrexone, zonisamide, or topiramate, sometimes used alone or combined to support appetite, cravings, or blood sugar Treatment is tailored to your MetabolicPrint profile, health history, and weight-loss goals
Latest clinical data from 2026 reveals how the triple agonist mechanism achieves superior weight loss results and improves safety profiles compared to traditional GLP-1 options